Shanghai Hile Bio-Technology Co., Ltd. 603718.SS Stock
Shanghai Hile Bio-Technology Co., Ltd. Price Chart
Shanghai Hile Bio-Technology Co., Ltd. 603718.SS Financial and Trading Overview
Contents
Shanghai Hile Bio-Technology Co., Ltd. stock price | 8.2 CNY |
Previous Close | 9.34 CNY |
Open | 9.34 CNY |
Bid | 9.39 CNY x 0 |
Ask | 9.41 CNY x 0 |
Day's Range | 9.34 - 9.43 CNY |
52 Week Range | 9 - 12.61 CNY |
Volume | 2.25M CNY |
Avg. Volume | 3.52M CNY |
Market Cap | 6.05B CNY |
Beta (5Y Monthly) | 0.871917 |
PE Ratio (TTM) | 46.999996 |
EPS (TTM) | 0.24 CNY |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | July 1, 2021 |
1y Target Est | N/A |
603718.SS Valuation Measures
Enterprise Value | 5.9B CNY |
Trailing P/E | 46.999996 |
Forward P/E | 37.6 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 21.155653 |
Price/Book (mrq) | 5.322763 |
Enterprise Value/Revenue | 20.617 |
Enterprise Value/EBITDA | 113.138 |
Trading Information
Shanghai Hile Bio-Technology Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.871917 |
52-Week Change | -17.19% |
S&P500 52-Week Change | 20.43% |
52 Week High | 12.61 CNY |
52 Week Low | 9 CNY |
50-Day Moving Average | 10.28 CNY |
200-Day Moving Average | 10.59 CNY |
603718.SS Share Statistics
Avg. Volume (3 month) | 3.52M CNY |
Avg. Daily Volume (10-Days) | 3.15M CNY |
Shares Outstanding | 644M |
Float | 287.13M |
Short Ratio | N/A |
% Held by Insiders | 59.40% |
% Held by Institutions | 1.04% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.057 |
Trailing Annual Dividend Yield | 0.61% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 23:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 43.77% |
Operating Margin (ttm) | 5.23% |
Gross Margin | 59.23% |
EBITDA Margin | 18.22% |
Management Effectiveness
Return on Assets (ttm) | 0.56% |
Return on Equity (ttm) | 10.74% |
Income Statement
Revenue (ttm) | 286.15M CNY |
Revenue Per Share (ttm) | 0.45 CNY |
Quarterly Revenue Growth (yoy) | -16.30% |
Gross Profit (ttm) | 176.9M CNY |
EBITDA | 52.14M CNY |
Net Income Avi to Common (ttm) | 125.25M CNY |
Diluted EPS (ttm) | 0.2 |
Quarterly Earnings Growth (yoy) | 34.39% |
Balance Sheet
Total Cash (mrq) | 321.14M CNY |
Total Cash Per Share (mrq) | 0.5 CNY |
Total Debt (mrq) | 235.63M CNY |
Total Debt/Equity (mrq) | 21.28 CNY |
Current Ratio (mrq) | 2.194 |
Book Value Per Share (mrq) | 1.766 |
Cash Flow Statement
Operating Cash Flow (ttm) | 308.63M CNY |
Levered Free Cash Flow (ttm) | 228.34M CNY |
Profile of Shanghai Hile Bio-Technology Co., Ltd.
Country | China |
State | N/A |
City | Shanghai |
Address | Economic Development Zone |
ZIP | 201403 |
Phone | 86 21 6089 0888 |
Website | https://www.hile-bio.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 491 |
Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; inactivated vaccine for streptococcus suis; pseudorabies live vaccines; inactivated oil emulsion vaccine of porcine parvovirus disease; pathogenic porcine reproductive and respiratory syndrome live vaccines; transmissible gastroenteritis, porcine epidemic diarrhea, and porcine rotavirus triple live vaccines; porcine reproductive and respiratory syndrome live vaccines; swine transmissible gastroenteritis and swine epidemic diarrhea combined inactivated vaccines; porcine circovirus type 2 inactivated vaccines; and swine Japanese encephalitis live vaccines. It also provides chicken infectious bursal disease live vaccines; inactivated avian infectious rhinitis vaccines; newcastle disease and avian influenza combined inactivated vaccines; newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; avian influenza inactivated vaccines; newcastle disease, infectious bronchitis, and avian influenza triple inactivated vaccines; avian infectious bronchitis live vaccines; avian newcastle disease and avian infectious bronchitis combined live vaccines; newcastle disease low virulent live vaccines; Marek's disease turkey herpes virus live vaccines; and fowlpox live vaccines. The company was founded in 1981 and is based in Shanghai, China.
Q&A For Shanghai Hile Bio-Technology Co., Ltd. Stock
What is a current 603718.SS stock price?
Shanghai Hile Bio-Technology Co., Ltd. 603718.SS stock price today per share is 8.2 CNY.
How to purchase Shanghai Hile Bio-Technology Co., Ltd. stock?
You can buy 603718.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shanghai Hile Bio-Technology Co., Ltd.?
The stock symbol or ticker of Shanghai Hile Bio-Technology Co., Ltd. is 603718.SS.
Which industry does the Shanghai Hile Bio-Technology Co., Ltd. company belong to?
The Shanghai Hile Bio-Technology Co., Ltd. industry is Biotechnology.
How many shares does Shanghai Hile Bio-Technology Co., Ltd. have in circulation?
The max supply of Shanghai Hile Bio-Technology Co., Ltd. shares is 657.9M.
What is Shanghai Hile Bio-Technology Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Shanghai Hile Bio-Technology Co., Ltd. PE Ratio is 34.16666800 now.
What was Shanghai Hile Bio-Technology Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Shanghai Hile Bio-Technology Co., Ltd. EPS is 0.24 CNY over the trailing 12 months.
Which sector does the Shanghai Hile Bio-Technology Co., Ltd. company belong to?
The Shanghai Hile Bio-Technology Co., Ltd. sector is Healthcare.
Stocks Related By Marketcap
- Shandong Lukang Pharmaceutical Co.,Ltd. 600789.SS Stock
- Jiangsu High Hope International Group Corporation 600981.SS Stock
- Jiangsu Boqian New Materials Stock Co., Ltd. 605376.SS Stock
- Weihai Guangtai Airport Equipment Co.,Ltd 002111.SZ Stock
- Shenzhen Jieshun Science and Technology Industry Co.,Ltd. 002609.SZ Stock